What is the recommended dosage and administration of Nexium (Esomeprazole) for an 8-month-old, 9.8kg infant with Gastroesophageal Reflux Disease (GERD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nexium (Esomeprazole) Dosing for an 8-Month-Old, 9.8kg Infant with GERD

For this 9.8kg infant, administer esomeprazole 1 mg/kg once daily, which equals approximately 10mg (one full sachet) once daily, given 30 minutes before the morning feeding. 1

Weight-Based Dose Calculation

  • Standard dosing: Esomeprazole 1 mg/kg once daily is the established dose for infants 1-24 months with GERD 1
  • For this 9.8kg infant: 9.8kg × 1 mg/kg = 9.8mg, which rounds to the available 10mg sachet formulation 1
  • Alternative lower dose: A 0.25 mg/kg dose (approximately 2.5mg) can be used initially, but provides less acid suppression and symptom control 1

How to Administer the 10mg Sachet

Preparation method 1:

  • Empty the entire 10mg sachet contents into a small container
  • Add 5-10mL of water (do NOT use other liquids like milk or juice)
  • Stir well to create a suspension
  • Administer the entire mixture immediately using an oral syringe
  • Rinse the container with another 5mL of water and give this to ensure full dose delivery

Timing is critical 2:

  • Give approximately 30 minutes BEFORE the morning feeding for optimal acid suppression 2
  • Consistent daily timing improves efficacy 1

Clinical Evidence Supporting This Dose

  • Acid suppression data: The 1 mg/kg dose increases intragastric pH >4 for 69.3% of the 24-hour period (compared to only 47.9% with the 0.25 mg/kg dose) 1
  • Symptom reduction: The 1 mg/kg dose reduces esophageal acid exposure from 12.5% to 5.5% of time with pH <4 (P < 0.001) 1
  • Safety profile: Both 0.25 mg/kg and 1 mg/kg doses were well tolerated in infants 1-24 months old 1

Important Clinical Considerations

Monitoring and follow-up 2:

  • Reassess symptoms after 2-4 weeks of therapy 2
  • If symptoms persist despite adequate dosing, consider upper endoscopy to exclude other diagnoses 2
  • Long-term use beyond 8-12 weeks should prompt re-evaluation of the diagnosis 2

Common pitfalls to avoid:

  • Do NOT use adult dosing: The 20mg or 40mg doses used in adolescents are inappropriate for infants 3
  • Do NOT mix with formula or milk: This alters absorption and reduces efficacy 1
  • Do NOT give with meals: Proton pump inhibitors require administration 30 minutes before feeding for optimal effect 2

Potential adverse effects 3:

  • Headache, abdominal pain, nausea, and diarrhea are most common (though less frequent in infants than adolescents) 3
  • Monitor for increased risk of community-acquired pneumonia with chronic acid suppression 2

When to Escalate or Modify Therapy

If inadequate response after 2-4 weeks 2, 1:

  • Consider increasing to 1.5 mg/kg once daily (approximately 15mg for this infant) 1
  • Evaluate medication timing and administration technique 2
  • Rule out other diagnoses through endoscopy if symptoms are severe or refractory 2

Duration of therapy 2:

  • Initial trial should be 4-8 weeks 2
  • Chronic therapy beyond this requires careful risk-benefit assessment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.